论文部分内容阅读
2001年,辉瑞公司的阿伐他汀,销售额70亿美元,名列第一位;默克公司的辛代他汀,销售额53亿美元,名列第三位;销售额进入前十位的还有施贵宝公司的普伐他汀……这是2001年IMS的世界10大畅销药调查报告。 据业内权威人士预测,2002年的世界10大畅销药中,阿伐他汀及辛伐他汀会再次位居三甲。就是这些调脂药在国际医药舞台上大展身手,尽展风流,为其主建立霸业立下了赫赫功勋。也就是这些“重磅炸弹”型的产品创造了全球药物市场的一个个销售额“神话”！ 自二次大战结束后的50多年来,世界医药工业涌现出一大批畅销药物。只要仔细分析
In 2001, Pfizer’s atorvastatin ranked first with sales of 7 billion U.S. dollars. Merck’s Xin Ting statin, with sales of 5.3 billion U.S. dollars, ranked third with sales of the top ten There is a pravastatin company of pravastatin ... ... This is the 2001 IMS 10 world’s best-selling drug survey. According to industry authorities predict that in 2002 the world’s top 10 best-selling drugs, atorvastatin and simvastatin will once again ranked the top three. It is these lipid-lowering drugs to show their talents in the international arena of medicine, to show their own dedication, for the establishment of its dominant tyrants established illustrious contributions. That is, these “blockbuster” products have created “myths” of sales in the global pharmaceutical market! More than 50 years after World War II, the world’s pharmaceutical industry emerged in a large number of best-selling drugs. Just carefully analyze